Immune cells in the tumor microenvironment - Mechanisms responsible for functional and signaling defects

Advances in Experimental Medicine and Biology

Volumn 451, Issue , 1998, Pages 167-171

  Whiteside, Theresa L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL LINE; MALIGNANT NEOPLASTIC DISEASE; NATURAL KILLER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR BIOPSY; TUMOR IMMUNITY; TUMOR IMMUNOLOGY;

ANTIGENS, CD3; APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU NICK-END LABELING; JURKAT CELLS; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); LYMPHOCYTES, TUMOR-INFILTRATING; MEMBRANE PROTEINS; MOUTH MUCOSA; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IGG; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 0031723742     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5357-1_27     Document Type: Article

References (9)

1. TL Whiteside, 1993: Tumor-Infiltrating Lymphocytes in Human Malignancies. R.G. Landes Co., Austin, Texas.
2. TL Whiteside, S Miescher, J Hullimann, V Von Fliedner, 1986: Phenotyping and limiting-dilution analysis of T-lymphocytes infiltrating human solid tumors. Int. J. Cancer 37, 803-811.
3. Y Gavrieli, SA Sherman, Ben-Sasson, 1992: Identification of programmed cell death in situ via specific labeling of DNA fragmentation. J. Cell Biol. 119, 493-501.
4. H Rabinowich, M Banks, TE Reichert, et al, 1996: Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after IL-2 therapy. Clin. Cancer Res. 2, 1263-74.
5. DS Heo, CH Snyderman, SM Gollin, et al, 1989: Biology, cytogenetics and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res. 49, 5167-75.
6. P Matzinger, 1991: The JAM test. J. Immunol. Methods 145, 185-192.
7. H Rabinowich, TE Reichert, Y Kashii, MC Bell, TL Whiteside, 1997: Lymphocyte apoptosis induced by Fas Ligand-expressing ovarian carcinoma cells: implications for altered expression of TCR in tumor. Submitted.
8. TE Reichert, H Rabinowich, JT Johnson, TL Whiteside, 1997: Human immune cells in the tumor microenvironment: mechanisms responsible for signaling and functional defects. J. Immunother. In Press.
9. J O'Connell, GC O'Sullivan, JK Collins, F Shanahan, 1996: The Fas counterattack: Fas-mediated T-cell killing by colon cancer cells expressing Fas ligand. J Exp. Med. 184, 1075-82.